Stefan Imobersteg Selected Research

Stefan Imobersteg Research Topics

3	Neoplasms (Cancer) 12/2021 - 01/2020
2	Stroke (Strokes) 01/2020 - 10/2019
1	Spinal Cord Injuries (Spinal Cord Injury) 10/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Fatigue 10/2019
1	Cataplexy 12/2012

3	minigastrinIBA 12/2021 - 01/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2021 - 01/2020
2	Everolimus FDA Link 12/2021 - 01/2020
2	Cholecystokinin B ReceptorIBA 11/2020 - 01/2020
2	Radioisotopes (Radionuclides)IBA 11/2020 - 01/2020
2	AntibodiesIBA 01/2020 - 10/2019
1	TOR Serine-Threonine KinasesIBA 12/2021
1	Actinium-225IBA 11/2020
1	PlasticsIBA 10/2020
1	alanyltyrosineIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2020
1	Peptide Receptors (Peptide Receptor)IBA 01/2020
1	aspartyl-phenylalanine (aspartylphenylalanine)IBA 01/2020
1	glycyltryptophanIBA 01/2020
1	LigandsIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Biological ProductsIBA 10/2019
1	almorexantIBA 12/2012
1	OrexinsIBA 12/2012

3	Therapeutics 11/2020 - 01/2020
1	Immunotherapy 10/2019